XRCC4 and ovarian cancer: To further support the cJUN mediate the transcription of XRCC4 in ovarian cancer cells exposed to cisplatin, we perform a ChIP assay to monitor the endogenous binding of cJUN to XRCC4 promoter region in the chromosome in both A2780cisR and SKOV3cisR cell lines treated with cisplatin.